New study aims to quiet delirium in dying cancer patients
NCT ID NCT03743649
First seen Jan 11, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This study looks at how well two drugs, haloperidol and lorazepam, can control severe agitation and confusion (delirium) in advanced cancer patients in palliative care. About 110 patients whose symptoms don't improve with low-dose haloperidol will receive different drug strategies. The goal is to find the best way to calm these symptoms and reduce stress for both patients and their caregivers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELIRIUM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hosptial de Cancer de Barretos
Barretos, São Paulo, 14784, Brazil
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Virginia Commonwealth University/Massey Cancer Center
Richmond, Virginia, 23298, United States
Conditions
Explore the condition pages connected to this study.